Client News

Destiny Pharma: XF-73 Dermal infection project advances into clinically enabling safety study with US Government’s NIAID

Mainz Biomed Announces U.S. Extension of ColoFuture Study to Evaluate Integration of Novel mRNA Biomarkers into ColoAlert

LINDIS Biotech Presented Encouraging Data from High Risk-Non-Muscle-Invasive Bladder Cancer Patients Treated with Trifunctional Antibody CATUMAXOMAB at EMUC22

invIOs presents positive patient data from ongoing Phase 1b trial of APN401 cell therapy in advanced solid tumors at SITC 2022

ONWARD’s Research Partner .NeuroRestore Publishes Groundbreaking Paper Identifying Neurons that Restore Walking after Paralysis

Atriva Therapeutics appoints Christian Pangratz as Chief Executive Officer, implementing planned management change

InflaRx Reports Third Quarter 2022 Financial & Operating Results

ONWARD Reports Third Quarter 2022 Highlights and Provides Business Update

ONWARD Schedules Webcast to Provide Third Quarter Business Update and Announces Participation at Upcoming Conferences

avateramedical to present at ERUS meeting after successful completion of first live surgery at DRUS congress